Molecular characterization of Histoplasma capsulatum isolated from an outbreak in treasure hunters Histoplasma capsulatum in treasure hunters.
BACKGROUND
In Mexico, primary pulmonary histoplasmosis is the most relevant clinical form of the disease. The geographical distribution of specific strains of Histoplasma capsulatum circulating in Mexico has not been fully established. Outbreaks must be reported in order to have current, updated information on this disease, identifying new endemic areas, manner of exposure to the fungi, and molecular characterization of the causative agents. We report a recent outbreak of histoplasmosis in treasure hunters and the molecular characterization of two isolates obtained from these patients.


METHODS
Six patients admitted to the National Institute of Respiratory Diseases (INER) in Mexico City presented severe respiratory symptoms suggestive of histoplasmosis. They acquired the infection in the Veracruz (VZ) endemic zone. Diagnosis was made by X-ray and Computed tomography (CT), liver function, immunological techniques, and culture. Identification of H. capsulatum isolates was confirmed by using Polymerase chain reaction (PCR) was conducted with a probe from the M antigen, and the isolates were characterized by means of Random amplification of polymorphic DNA (RAPD)-PCR employed the 1253 oligonucleotide and a mixture of oligonucleotides 1281 and 1283. These were compared to eight reference strain isolates from neighboring areas.


RESULTS
X-ray and CT revealed disseminated micronodular images throughout lung parenchyma, as well as bilateral retrocaval, prevascular, subcarinal, and hilar adenopathies, hepatosplenomegaly, and altered liver function tests. Five of the six patients developed disseminated histoplasmosis. Two H. capsulatum strains were isolated. The same band profile was detected in both strains, indicating that both isolates corresponded to the sole H. capsulatum strain. Molecular characterization of the isolates was similar in 100% with the EH-53 Hidalgo human (HG) strain (reference strain integrated into the LAm A clade described for Latin America).


CONCLUSIONS
The two isolates appeared to possess the same polymorphic pattern; they are indistinguishable from each other and from EH-53. It is important to remain updated on recent outbreaks of histoplasmosis, the manner of exposure to the fungi, as well as the molecular characterization of the isolates. The severity of cases indicates that this strain is highly virulent and that it is probably prevalent in Hidalgo and Veracruz states.
Muñoz
Bertha
B
Laboratorio de Micología Médica, Depto, de Investigación en Virología, Instituto Nacional de Enfermedades Respiratorias (INER), Calzada de Tlalpan 4502, Sección XVI, Tlalpan,14080 México, DF, México.
Martínez
María A
MA
Palma
Gabriel
G
Ramírez
Amado
A
Frías
María G
MG
Reyes
María R
MR
Taylor
María L
ML
Higuera
Anjarath L
AL
Corcho
Alexander
A
Manjarrez
María E
ME
D000328:Adult; D002648:Child; D016000:Cluster Analysis; D016172:DNA Fingerprinting; D004271:DNA, Fungal / Q000235:genetics; D004196:Disease Outbreaks; D005260:Female; D005838:Genotype; D006658:Histoplasma / Q000145:classification* / Q000235:genetics* / Q000302:isolation & purification; D006660:Histoplasmosis / Q000453:epidemiology* / Q000382:microbiology*; D006801:Humans; D008172:Lung Diseases, Fungal / Q000453:epidemiology* / Q000382:microbiology*; D008297:Male; D008800:Mexico / Q000453:epidemiology; D008875:Middle Aged; D017720:Molecular Epidemiology; D016533:Mycological Typing Techniques; D019105:Random Amplified Polymorphic DNA Technique
D004271:DNA, Fungal
Mol Ecol. 2003 Dec;12(12):3383-401
14629354
Annu Rev Microbiol. 1987;41:209-25
3318668
J Clin Microbiol. 1976 Feb;3(2):191-9
56339
Mycoses. 1993 Jan-Feb;36(1-2):25-30
8316258
Fungal Genet Biol. 2000 Aug;30(3):207-12
11035942
FEMS Immunol Med Microbiol. 2005 Sep 1;45(3):451-8
16061361
J Bacteriol. 1992 Nov;174(22):7075-9
1429430
J Bacteriol. 1986 Mar;165(3):813-8
3005239
Mykosen. 1977 Oct;20(10):393-9
562981
Mycoses. 1996 Sep-Oct;39(9-10):375-9
9009662
Gac Med Mex. 1961 Jan;91:5-11
13706941
J Clin Microbiol. 1992 Aug;30(8):2104-7
1354224
J Clin Microbiol. 1999 May;37(5):1404-8
10203495
J Clin Microbiol. 2003 Feb;41(2):535-9
12574242
Medicine (Baltimore). 2008 Jul;87(4):193-202
18626302
Rev Inst Salubr Enferm Trop. 1963 Jun;23:65-80
14104626
J Immunol. 1960 Oct;85:387-90
13696147
J Clin Microbiol. 1993 Feb;31(2):463-4
8432840
Clin Microbiol Rev. 1991 Oct;4(4):411-21
1747859
Infect Immun. 1989 May;57(5):1409-12
2565290
Rev Invest Salud Publica. 1971 Apr-Jun;31(2):74-7
5124655
FEMS Immunol Med Microbiol. 2005 Sep 1;45(3):435-41
16061362
Rev Invest Salud Publica. 1975 Jan-Mar;35(1):85-96
1179079
J Clin Microbiol. 1999 Mar;37(3):653-63
9986828
Medicine (Baltimore). 2007 May;86(3):162-169
17505255
Bol Med Hosp Infant Mex. 1993 Dec;50(12):870-5
8110405
Am J Trop Med Hyg. 2003 Dec;69(6):663-9
14740886